Dengue Moment
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
The World Health Organization (WHO) has donated 2,160 doses of Ebola trial vaccine to Uganda to evaluate the efficacy of the vaccine in combating the virus which in the recent outbreak has killed a health worker in Kampala, the country's capital.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
He was speaking as India’s G20 Sherpa at the first Sherpa meeting convened by Indonesia, the current G20 President, in virtual mode.
PM Modi took to social media platform, Twitter to laud the state government which was shared by Thakur who thanked him for continued support to the government that led to the achieving of the vaccination target.
As with other age groups, the use of this vaccine in children aged 5-11 years should be given in two doses at least 3 weeks apart.
Veena Kumari, Patna civil surgeon, said the irregularities were detected at centres located at Patna Polytechnic College, Kankarbagh health centre and Patliputra sports complex.
It took Bangladesh about 10 months to reach the milestone of administering more than 100 million COVID vaccine doses.
